141 related articles for article (PubMed ID: 21046269)
1. Survival implications of cervical lymphadenectomy in patients with medullary thyroid cancer.
Kandil E; Gilson MM; Alabbas HH; Tufaro AP; Dackiw A; Tufano RP
Ann Surg Oncol; 2011 Apr; 18(4):1028-34. PubMed ID: 21046269
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of lymph node yield and metastatic lymph node ratio in medullary thyroid carcinoma.
Leggett MD; Chen SL; Schneider PD; Martinez SR
Ann Surg Oncol; 2008 Sep; 15(9):2493-9. PubMed ID: 18594930
[TBL] [Abstract][Full Text] [Related]
3. [Lymphadenectomy in thyroid gland carcinoma--staging and therapy].
Pomorski L; Rybinski K
Zentralbl Chir; 1996; 121(6):455-8. PubMed ID: 8767330
[TBL] [Abstract][Full Text] [Related]
4. [Decision on the strategy of treatment of patients with medullary cancer of the thyroid].
Romanchishen AF; Lisovskiĭ OV
Vestn Khir Im I I Grek; 2006; 165(4):46-9. PubMed ID: 17120422
[TBL] [Abstract][Full Text] [Related]
5. Prognostic variables and calcitonin in medullary thyroid cancer.
Clark JR; Fridman TR; Odell MJ; Brierley J; Walfish PG; Freeman JL
Laryngoscope; 2005 Aug; 115(8):1445-50. PubMed ID: 16094121
[TBL] [Abstract][Full Text] [Related]
6. Influence of lymph node metastases on survival in pediatric medullary thyroid cancer.
Raval MV; Sturgeon C; Bentrem DJ; Elaraj DM; Stewart AK; Winchester DJ; Ko CY; Reynolds M
J Pediatr Surg; 2010 Oct; 45(10):1947-54. PubMed ID: 20920711
[TBL] [Abstract][Full Text] [Related]
7. Medullary thyroid cancer: are practice patterns in the United States discordant from American Thyroid Association guidelines?
Panigrahi B; Roman SA; Sosa JA
Ann Surg Oncol; 2010 Jun; 17(6):1490-8. PubMed ID: 20224861
[TBL] [Abstract][Full Text] [Related]
8. [Surgical management of upper mediastinal lymph nodes metastases from thyroid carcinoma].
Li ZJ; Miao XX; Tang PZ; Xu ZG; Zhang DC
Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):145-7. PubMed ID: 16750024
[TBL] [Abstract][Full Text] [Related]
9. Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients.
Pelizzo MR; Boschin IM; Bernante P; Toniato A; Piotto A; Pagetta C; Nibale O; Rampin L; Muzzio PC; Rubello D
Eur J Surg Oncol; 2007 May; 33(4):493-7. PubMed ID: 17125960
[TBL] [Abstract][Full Text] [Related]
10. Metastatic lymph node ratio can further stratify risk for mortality in medullary thyroid cancer patients: A population-based analysis.
Qu N; Shi RL; Lu ZW; Liao T; Wen D; Sun GH; Li DS; Ji QH
Oncotarget; 2016 Oct; 7(40):65937-65945. PubMed ID: 27588396
[TBL] [Abstract][Full Text] [Related]
11. [Results of cervico-mediastinal lymphadenectomy using microsurgery technique in the treatment of occult metastases of papillary and medullary carcinoma of the thyroid gland].
Nicolosi M; Travagli JP; Chisari A; Compagnone S; Tornambene F; Pulvirenti G; Guarino D; Deodato G
Minerva Chir; 1998 Mar; 53(3):115-9. PubMed ID: 9617105
[No Abstract] [Full Text] [Related]
12. [Surgical treatment of differentiated carcinoma of the thyroid. Follow-up of 99 cases].
Pozzetto B; Roseano M; Dellach C; Leggeri A
Chir Ital; 2000; 52(1):49-56. PubMed ID: 10832526
[TBL] [Abstract][Full Text] [Related]
13. [Surgical therapy of differentiated thyroid gland carcinoma].
Walgenbach S; Sternheim E; Bittinger F; Junginger T
Zentralbl Chir; 1997; 122(4):252-8. PubMed ID: 9221635
[TBL] [Abstract][Full Text] [Related]
14. [Significance of lymph node metastases of differentiated thyroid gland carcinomas and C-cell carcinomas for prognosis--a meta-analysis].
Witte J; Schlotmann U; Simon D; Dotzenrath C; Ohmann C; Goretzki PE
Zentralbl Chir; 1997; 122(4):259-65. PubMed ID: 9221636
[TBL] [Abstract][Full Text] [Related]
15. [Medullary carcinoma of the thyroid].
Francomano F; Cotellese R; Scipione P; Ricci A; D'Aulerio A; Ricciardi A; Orlandi N; Napolitano L
G Chir; 1996 Oct; 17(10):535-42. PubMed ID: 9044606
[TBL] [Abstract][Full Text] [Related]
16. Medullary thyroid cancer: prognostic factors for survival and recurrence, recommendations for the extent of lymph node dissection and for surgical therapy in recurrent disease.
Pilaete K; Delaere P; Decallonne B; Bex M; Hauben E; Nuyts S; Clement P; Hermans R; Vander Poorten V
B-ENT; 2012; 8(2):113-21. PubMed ID: 22896930
[TBL] [Abstract][Full Text] [Related]
17. [Lymph node involvement and prognosis in medullary cancers of the thyroid gland].
Mathonnet M; Cubertafond P; Teissier MP; Boutros-Toni F; Gainant A
Chirurgie; 1994-1995; 120(12):117-22. PubMed ID: 8746014
[TBL] [Abstract][Full Text] [Related]
18. The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent.
Mariette C; Piessen G; Briez N; Triboulet JP
Ann Surg; 2008 Feb; 247(2):365-71. PubMed ID: 18216546
[TBL] [Abstract][Full Text] [Related]
19. Multifactorial analysis of survival and recurrences in differentiated thyroid cancer. Comparative evaluation of usefulness of AGES, MACIS, and risk group scores in Mexican population.
Rodríguez-Cuevas S; Labastida-Almendaro S; Cortés-Arroyo H; López-Garza J; Barroso-Bravo S
J Exp Clin Cancer Res; 2002 Mar; 21(1):79-86. PubMed ID: 12071534
[TBL] [Abstract][Full Text] [Related]
20. [Type of surgery for 147 patients with medullary carcinoma of the thyroid].
Huang CP; Zhu YX; Tian AL
Zhonghua Zhong Liu Za Zhi; 2003 Sep; 25(5):490-2. PubMed ID: 14575577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]